Rethink
skip navigation Home | About Us | News & media | Jobs | Contact us | Services | Groups
  • About mental illness
    • Who does it affect?
    • What causes mental illness?
    • How is mental illness diagnosed
    • Talking to doctors
    • Mental illnesses and disorders
    • Dual Diagnosis
    • Early intervention
    • People's experiences
  • Living with mental illness
    • Treatment and therapy
    • Recovery and self management
    • Everyday living
    • Money, debt & mental health problems
    • Coping in a crisis
    • Rights and laws
    • Caring
  • How we can help
    • Our services
    • Commissioning services
    • Our support groups
    • Campaigning for change
    • Research
    • Publications
    • Advice service and information
    • Northern Ireland
    • News and media
    • Rethink siblings
    • Your Voice
  • Get involved
    • Join us
    • Fundraise
    • Donate now
    • Leave a legacy
    • Events
    • Corporate and trust funding
    • Discussion forum

Clinical research news

Genes influence response to antidepressants

18 July 2008

Increased levels of alpha-defensin indicates risk for schizophrenia

09 July 2008

Skunk use associated with increased risk of developing psychosis

04 July 2008

Study of deep brain stimulation for major depressive disorder commences

01 July 2008

Depot formulation of olanzapine as effective and safe as oral formulation

27 June 2008

New study suggests that people with carers respond better to CBT

26 June 2008

Atypical antipsychotics associated with an increased risk of diabetes

19 June 2008

Returning to work aids recovery in depressed employees

05 June 2008

Researchers identify genetic mutations responsible for 10 percent of schizophrenia

03 June 2008

Study launched to test possible preventive intervention for schizophrenia in young people

02 June 2008

  1. 1
  2. 2

Next >

  • How we can help
    • Our services
    • Commissioning services
    • Our support groups
    • Campaigning for change
    • Research
      • Clinical research news
    • Publications
    • Advice service and information
    • Northern Ireland
    • News and media
    • Rethink siblings
    • Your Voice
Clinical research news RSS feed
Top of page
 Print this page
 Send this page to a friend
 Donate
 Members
 My Rethink
 Email updates
 Discussion forum
 Blogs
Accessibility | Privacy | Sitemap | A to Z
Tel. 0845 456 0455 | Site by Torchbox | Updated 14 May 2008
Rethink, registered in England as National Schizophrenia Fellowship, company number 1227970, charity number 271028. Registered office: 28 Castle Street, Kingston-Upon-Thames, Surrey, KT1 1SS.